Evidence map›Paper›PMID 17139538›Full record

ArticleVeterinary research communications2006

Optimized transduction of canine paediatric CD34(+) cells using an MSCV-based bicistronic vector.

S E Suter, T A Gouthro, P A McSweeney, R A Nash, M E Haskins, P J Felsburg, P S Henthorn

Abstract read
PubMed Publisher
In one paragraph

Article in Veterinary research communications, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Effects of over-expression of ANXA10 gene on proliferation and apoptosis of hepatocellular carcinoma cell line HepG2.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2012
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

S E SuterSection of Medical Genetics, Department of Clinical Studies, Philadelphia, Pennsylvania, USA. sesuter@vmth.ucdavis.edu
T A Gouthro
P A McSweeney
R A Nash
M E Haskins
P J Felsburg
P S Henthorn
University of Pennsylvania · USFred Hutch Cancer Center · USUniversity of Colorado Denver · US

Funding

X-LINKED SEVERE COMBINED IMMUNODEFICIENCY IN THE DOGP40RR002512 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI HASKINS, MARK E · 1985 to 2011
$7.6M
Gene Therapy of Mucopolysaccharidosis VIIR01DK054481 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI CASAL, MARGRET L · 1998 to 2017
$7.0M
GENE THERAPY FOR CANINI X-SCIDR01AI043745 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI FELSBURG, PETER J · 1998 to 2012
$6.3M
TRAINING IN COMPARITIVE MEDICAL &MOLECULAR GENETICST32RR007063 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI WOLFE, JOHN H · 1996 to 2011
$1.8M
USE OF SCID &IMMUNOCOMPETENT MICE TO ANALYZE PATHOGENESIS OF ORAL LISTERIOSISP01RR012211 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI ROZMIAREK, HARRY NMN · 1998 to 2002
$863k
X LINKED SEVERE COMBINED IMMUNODEFICIENCY IN DOG AND MANR01AI033177 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HENTHORN, PAULA S · 1993 to 1998
–
NCRR NIH HHS P40 RR002512NCRR NIH HHS RR02512NCRR NIH HHS RR12211NCRR NIH HHS RR T3207063NIAID NIH HHS AI33177NIAID NIH HHS AI43745NIAID NIH HHS R01 AI043745NIDDK NIH HHS DK54481
6 · The paper itself

Abstract

We have used a murine MSCV-based bicistronic retroviral vector, containing the common gamma chain (gammac) and enhanced green fluorescent protein (EGFP) cDNAs, to optimize retroviral transduction of canine cells, including an adherent canine thymus fibroblast cell line, Cf2Th, as well as normal canine CD34(+) bone marrow (BM) cells. Both canine cell types were shown to express Ram-1 (the amphotropic retroviral receptor) mRNA. Supernatants containing infectious viruses were produced using both stable (PA317) and transient (Phoenix cells) amphotropic virus producer cell lines. Centrifugation (spinfection) combined with the addition of polybrene produced the highest transduction efficiencies, infecting approximately 75% of Cf2Th cells. An average of 11% of highly enriched canine CD34(+) cells could be transduced in a protocol that utilized spinfection and plates coated with the fibronectin fragment CH-296 (Retronectin). Indirect assays showed the vector-encoded canine gammac cDNA produced a gammac protein that was expressed on the cell surface of transduced cells. This strategy may result in the transduction of sufficient numbers of CD34(+) BM cells to make the treatment of canine X-linked severe combined immunodeficiency and other canine genetic diseases feasible.

Indexed as

DogsAnimalsAntigens, CD34Bone Marrow CellsCell LineFibroblastsGenesGenetic VectorsMiceRetroviridaeStem CellsThymus GlandTransduction, GeneticAntigens, CD34

Identifiers

PMID17139538
OpenAlexW2119478027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.